Hepatitis C virus replication in patients with occult hepatitis C virus infection

Hepatology

Volumn 49, Issue 6, 2009, Pages 2128-2129

  Carreño, Vicente ^a   Bartolomé, Javier ^a   Castillo, Immaculada ^a   Quiroga, Juan Antonio ^a  

^a Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HEPATITIS C ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

CD4+ T LYMPHOCYTE; HEPATITIS C; HUMAN; LETTER; LIVER BIOPSY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; ULTRACENTRIFUGATION; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION;

HEPACIVIRUS; HEPATITIS C; HUMANS; VIRUS REPLICATION;

EID: 68949119565     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22936     Document Type: Letter

References (11)

1. Welker MW, Zeuzem S. Occult hepatitis C: How convincing are the current data? HEPATOLOGY 2009;49:665-675.
2. Carreño V, Bartolomé J, Castillo I, Quiroga JA. Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 2008; 18:139-157.
3. Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol. In press.
4. MacParland SA, Pham TN, Guy CS, Michalak TI. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. HEPATOLOGY 2009; doi:10.1002/hep.22802.
5. Tagiuri NI, McClure P, Ryder SD, Irving WL. Occult hepatitis C infection in patients with histological hepatitis and negative serum PCR for HCV [Abstract]. J Hepatol 2006;44(S2):S157.
6. Halfon P, Bourliere M, Ouzan D, Sene D, Saadoun D, Khiri H, et al. Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay. J Clin Microbiol 2008;46:2106-2108.
7. Quiroga JA, Castillo I, Llorente S, Bartolomé J, Barril G, Carreño V. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope. J Hepatol 2009;50:256-263.
8. Esaki T, Suzuki N, Yokoyama K, Iwata K, Irie M, Anan A, et al. Hepatocellular carcinoma in a patient with liver cirrhosis associated with negative serum HCV test but positive liver tissue HCV-RNA. Internal Med 2004; 43:279-282.
9. Comar M, Dal Molin G, D'Agaro P, Croce SL, Tribelli C, Campillo C. HBV, HCV and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: Comparison with blood markers. J Clin Pathol 2006;59:526-529.
10. Verslype C, Nevens F, Sinelli N, Clarysse C, Pirenne J, Depla E, et al. Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. J Hepatol 2003;38:208-214.
11. El-Sayed GM, Mohamed WS, Nouh MA, Moneer MM, El-Mahallawy HA. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients. Egypt J Immunol 2006;13:105-114.